Following an application from the Institute of Biotechnology, Sera and Vaccines Biomed SA, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of Lactoral on the improvement of the general immunity (Question No EFSA-Q-2008-477) [The EFSA Journal (2008) 860, pp. 1-8.]. The claim proposed by the applicant was worded as follows: ‘Lactoral is recommended in order to improve the general immunity by maintaining the microbiological balance’.
Recital 15, Commission Regulation (EC) No 1024/2009 of 29 October 2009 on the authorisation and refu…
In forcesince 29 Oct 2009